The latest patent battle battle between Illumina Inc. and Ariosa Diagnostics Inc. over Ariosa’s Harmony prenatal test ended quicker than the first.
U.S. District Judge Susan Illston on Monday ruled that two new patents asserted by Illumina are directed to natural phenomena and are ineligible for patent protection under Section 101. Her 14-page order snuffs out a suit that Illumina filed in May, just a few months after winning a $27 million jury verdict against Ariosa based on older patents.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]